Jesse Hart

755 total citations
18 papers, 449 citations indexed

About

Jesse Hart is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Jesse Hart has authored 18 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in Jesse Hart's work include Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (3 papers) and Cardiac tumors and thrombi (3 papers). Jesse Hart is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (3 papers) and Cardiac tumors and thrombi (3 papers). Jesse Hart collaborates with scholars based in United States, Canada and United Kingdom. Jesse Hart's co-authors include Srinivas Mandavilli, Veronica Ulici, Andrew Ricci, Quing Zhu, Mark Kane, Edward Cronin, Behnoosh Tavakoli, Poornima Hegde, Yan Xu and Susan Tannenbaum and has published in prestigious journals such as Radiology, Molecular Cancer Therapeutics and Cancers.

In The Last Decade

Jesse Hart

15 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse Hart United States 9 228 222 150 75 74 18 449
Mika Sampo Finland 14 178 0.8× 305 1.4× 115 0.8× 116 1.5× 128 1.7× 35 461
Stéphane Cherix Switzerland 13 143 0.6× 278 1.3× 55 0.4× 132 1.8× 240 3.2× 35 566
Stephen Schlicht Australia 12 61 0.3× 195 0.9× 78 0.5× 115 1.5× 155 2.1× 42 445
Yasuo Yazawa Japan 13 274 1.2× 368 1.7× 103 0.7× 143 1.9× 218 2.9× 51 635
Makoto Ieguchi Japan 12 147 0.6× 332 1.5× 58 0.4× 189 2.5× 143 1.9× 35 539
Primo Andrea Daolio Italy 12 93 0.4× 233 1.0× 55 0.4× 154 2.1× 121 1.6× 25 410
Taisuke Tanizawa Japan 13 203 0.9× 335 1.5× 63 0.4× 210 2.8× 160 2.2× 51 535
David Slosky United States 10 126 0.6× 89 0.4× 108 0.7× 21 0.3× 44 0.6× 18 336
Heng Wang China 11 63 0.3× 60 0.3× 55 0.4× 110 1.5× 108 1.5× 76 462
Kazuhiro Majima Japan 12 100 0.4× 151 0.7× 50 0.3× 40 0.5× 303 4.1× 20 724

Countries citing papers authored by Jesse Hart

Since Specialization
Citations

This map shows the geographic impact of Jesse Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Hart more than expected).

Fields of papers citing papers by Jesse Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Hart. The network helps show where Jesse Hart may publish in the future.

Co-authorship network of co-authors of Jesse Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Hart. A scholar is included among the top collaborators of Jesse Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Hart. Jesse Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Liu, Don S. Dizon, Thomas A. DiPetrillo, et al.. (2025). Clinicopathological and molecular analysis of a dermatofibrosarcoma protuberans with fibrosarcomatous transformation in the breast. npj Precision Oncology. 9(1). 107–107.
2.
Sun, Xiaojuan, Jesse Hart, Ross Taliano, et al.. (2025). ASPH Is a Metastatic Factor and Therapeutic Target in Chondrosarcoma. Cancers. 17(6). 951–951. 1 indexed citations
3.
Hart, Jesse, et al.. (2023). Genomic and Molecular Characteristics of Ovarian Carcinosarcoma. American Journal of Clinical Oncology. 46(12). 572–576. 3 indexed citations
4.
Tang, Oliver Y., et al.. (2022). Navigation-assisted resection of tumoral calcinosis of the lumbosacral spine: illustrative case. Journal of Neurosurgery Case Lessons. 4(4). CASE22213–CASE22213. 3 indexed citations
5.
Hart, Jesse, et al.. (2021). The effect that pathologic and radiologic interpretation of invasive and non-invasive areas in lung adenocarcinoma has on T-stage and treatment. Annals of Diagnostic Pathology. 54. 151799–151799. 2 indexed citations
6.
Ulici, Veronica & Jesse Hart. (2021). Chordoma. Archives of Pathology & Laboratory Medicine. 146(3). 386–395. 49 indexed citations
7.
Hart, Jesse, et al.. (2021). Primary Fallopian Tube Mullerian Adenosarcoma With Sarcomatous Overgrowth and a Previously Unreported MEIS1-NCOA2 Gene Fusion. International Journal of Gynecological Pathology. 41(1). 82–85. 5 indexed citations
8.
Miller, David T., Isidro Cortés‐Ciriano, Nischalan Pillay, et al.. (2020). Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes. 11(4). 387–387. 13 indexed citations
9.
Hartnett, Davis A., et al.. (2020). The Great Imposter: A Confusing Case of a Rare Renal Cell Carcinoma.. PubMed. 103(10). 35–37.
10.
Sun, Xiaojuan, Yupeng Chen, Hongchuan Yu, et al.. (2019). Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma. Molecular Cancer Therapeutics. 18(11). 2021–2029. 32 indexed citations
11.
Day, Kristopher M., et al.. (2016). A case of recurrent desmoplastic malignant melanoma presenting as empyema with underlying lung mass. Journal of Surgical Case Reports. 2016(4). rjw029–rjw029.
12.
Yoo, Don C., et al.. (2015). PET/CT Helps Downgrade an Aggressive-Appearing Rib Mass to a Probable Benign Lesion in a 9-Year-Old Girl. Clinical Nuclear Medicine. 41(3). 221–223. 2 indexed citations
13.
Hart, Jesse, Mark Edgar, & Jerad M. Gardner. (2014). Vascular tumors of bone. Seminars in Diagnostic Pathology. 31(1). 30–38. 15 indexed citations
14.
Zhu, Quing, Patricia DeFusco, Andrew Ricci, et al.. (2012). Breast Cancer: Assessing Response to Neoadjuvant Chemotherapy by Using US-guided Near-Infrared Tomography. Radiology. 266(2). 433–442. 73 indexed citations
15.
Hart, Jesse & Srinivas Mandavilli. (2011). Epithelioid angiosarcoma: a brief diagnostic review and differential diagnosis.. Archives of Pathology & Laboratory Medicine. 135(2). 268–72. 102 indexed citations
16.
Hart, Jesse & Srinivas Mandavilli. (2011). Epithelioid Angiosarcoma: A Brief Diagnostic Review and Differential Diagnosis. Archives of Pathology & Laboratory Medicine. 135(2). 268–272. 103 indexed citations
17.
Hart, Jesse, et al.. (2010). IMP3 immunocytochemical staining increases sensitivity in the routine cytologic evaluation of biliary brush specimens. Diagnostic Cytopathology. 40(4). 321–326. 23 indexed citations
18.
Hart, Jesse. (1970). Pulmonary sensitivity to nitrofurantoin.. BMJ. 2(5700). 51.3–52. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026